S100P and neoplasm: In the extracellular space, S100P interacts with the receptor for advanced-glycation end products to activate signal transduction pathways, including the mitogen-activated protein kinase, serine protein kinase, extracellular-regulated kinase, and nuclear factor pathways [16]–[18], and promote tumor development [19].